EVITA trial links daily vitamin C to fewer adverse events and possible longer survival
Researchers from the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team published results from the randomized, double-blind, placebo-controlled phase 2 EVITA trial in the American Cancer Society journal CANCER. The study enrolled 109 people with…
